Drug intelligence / Profile preview

Anti-aging Active Freeze-dried Powder Granules

Development stage: Preclinical
Lead developer: Reborn Health Management Consultation
Administration: Oral, Topical

Overview

Anti-aging Active Freeze-dried Powder Granules is a product being investigated in a clinical study for the treatment of acute novel coronavirus pneumonia (COVID-19). The name suggests potential broader anti-aging properties. It is developed by Guangzhou reborn health management consultation co., LTD.

Other names: Anti-aging Active

Beyond the preview

Go deeper on Anti-aging Active Freeze-dried Powder Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anti-aging Active Freeze-dried Powder Granules.

Explore the full profile